Stock listing
BSLN Stock Price, News, Filings & Events — Basilea Pharmaceutica Ag
Selected listing: BSLN · SIX · CHF · CH
This page tracks Basilea Pharmaceutica Ag's BSLN:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BSLN:SIX. BSLN:SIX is the stock-level entry point for investors researching Basilea Pharmaceutica Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Basilea Pharmaceutica AG, traded under the ticker BSLN, is a public company based in Switzerland with a market capitalization of approximately 786.57 million CHF. The company focuses on the development and commercialization of innovative therapies for the treatment of serious infections and cancer. Basilea is committed to advancing its pipeline of pharmaceutical products to address unmet medical needs.
- Ticker
- BSLN:SIX
- Asset type
- Stock
- Market cap
- $1.01B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX
- Currency
- CHF
Basilea Pharmaceutica Ag BSLN:SIX stock context
This page tracks Basilea Pharmaceutica Ag's BSLN:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BSLN:SIX. BSLN:SIX is the stock-level entry point for investors researching Basilea Pharmaceutica Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Basilea Pharmaceutica AG, traded under the ticker BSLN, is a public company based in Switzerland with a market capitalization of approximately 786.57 million CHF. The company focuses on the development and commercialization of innovative therapies for the treatment of serious infections and cancer. Basilea is committed to advancing its pipeline of pharmaceutical products to address unmet medical needs.
Latest news from Basilea Pharmaceutica Ag
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
August 5, 2026
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
July 29, 2026
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
April 15, 2026
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
April 9, 2026
Basilea Pharmaceutica Ag earnings calls
Research Basilea Pharmaceutica Ag
Basilea Pharmaceutica Ag investor report
Review AI stock analysis and investor report context for BSLN:SIX.
Basilea Pharmaceutica Ag company profile
View the public company page for Basilea Pharmaceutica Ag on 6ix.
Basilea Pharmaceutica Ag news
Read company news and market updates connected to Basilea Pharmaceutica Ag.
Basilea Pharmaceutica Ag investor events
Find investor webinars, events, and replay context for Basilea Pharmaceutica Ag.
Alternate listings
0QNA:LSE
GB · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
PK5:GETTEX
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
BSLNZ:AQUISUK
GB · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
BPMUF:OTC
US · USD
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
A0B9GA:LS
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
A0B9GA:LSX
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
PK5:TRADEGATE
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
PK5:BX
CH · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
PK5:MUN
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
BSLNZ:TURQUOISE
GB · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
PK5:DUS
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.
PK5:FWB
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is BSLN:SIX.